Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial

[1]  T. Jacobson.  The Lower the Better in Hypercholesterolemia Therapy: A Reliable Clinical Guideline? , 2000, Annals of Internal Medicine.

[2]  W. Brown.  Cholesterol lowering in atherosclerosis. , 2000, The American journal of cardiology.

[3]  Wollersheim,et al.  The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia , 2000, European journal of clinical investigation.

[4]  G. Mancini,et al.  Carotid intima-media thickness measurements: what defines an abnormality? A systematic review. , 1999, Clinical and investigative medicine. Medecine clinique et experimentale.

[5]  O. Faergeman,et al.  Effect of greater LDL-C reductions on prognosis-the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial , 1999 .

[6]  Tonstad,et al.  Carotid intima–media thickness and plaque in patients with familial hypercholesterolaemia mutations and control subjects , 1998, European journal of clinical investigation.

[7]  G. Boers,et al.  Carotid and femoral artery wall thickness and stiffness in patients at risk for cardiovascular disease, with special emphasis on hyperhomocysteinemia. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[8]  G. Mancia,et al.  Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. , 1998, Atherosclerosis.

[9]  G. Thorgeirsson,et al.  Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) , 1998, Circulation.

[10]  R H Selzer,et al.  The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events , 1998, Annals of Internal Medicine.

[11]  A. Folsom,et al.  Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. , 1997, American journal of epidemiology.

[12]  N. Nishi,et al.  Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. , 1997, Stroke.

[13]  Post Coronary Artery Bypass Graft Trial Investigators.  The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. , 1997, The New England journal of medicine.

[14]  A. Stalenhoef,et al.  Effect of Apheresis of Low-Density Lipoprotein on Peripheral Vascular Disease in Hypercholesterolemic Patients with Coronary Artery Disease , 1996, Annals of Internal Medicine.

[15]  S. Azen,et al.  Reduction in Carotid Arterial Wall Thickness Using Lovastatin and Dietary Therapy , 1996, Annals of Internal Medicine.

[16]  G. Schectman,et al.  Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals. , 1996, The American journal of medicine.

[17]  J. Salonen,et al.  Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. , 1995, Circulation.

[18]  D. Sprecher,et al.  Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[19]  P M Rautaharju,et al.  Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. , 1995, Stroke.

[20]  F. Leus,et al.  Influence of apolipoprotein(a) phenotype on lipoprotein(a) quantification: evaluation of three methods. , 1994, Clinical biochemistry.

[21]  C. Furberg,et al.  Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. , 1994, Circulation.

[22]  P. Touboul,et al.  Use of monitoring software to improve the measurement of carotid wall thickness by B-mode imaging , 1992, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[23]  M L Bots,et al.  Cardiovascular Determinants of Carotid Artery Disease: The Rotterdam Elderly Study , 1992, Hypertension.

[24]  Bob Margulies,et al.  Task force report , 1991 .

[25]  J. Hendriks,et al.  Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[26]  M J Malloy,et al.  Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. , 1990, JAMA.

[27]  M. Lopes-Virella,et al.  Immunonephelometric assay of human apolipoprotein AI. , 1980, Clinical Chemistry.

[28]  M. Trip,et al.  Rationale, Design and Baseline Characteristics of a Clinical Trial Comparing the Effects of Robust vs Conventional Cholesterol Lowering and Intima Media Thickness in Patients with Familial Hypercholesterolaemia , 2000, Clinical drug investigation.

[29]  A. Folsom,et al.  Variability in B-mode ultrasound measurements in the atherosclerosis risk in communities (ARIC) study. , 1996, Ultrasound in medicine & biology.